Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

221 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID).
Gendre JP, Mary JY, Florent C, Modigliani R, Colombel JF, Soulé JC, Galmiche JP, Lerebours E, Descos L, Viteau JM, et al. Gendre JP, et al. Among authors: lerebours e. Gastroenterology. 1993 Feb;104(2):435-9. doi: 10.1016/0016-5085(93)90411-5. Gastroenterology. 1993. PMID: 8425685 Clinical Trial.
A randomized, double-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine.
Lémann M, Mary JY, Colombel JF, Duclos B, Soule JC, Lerebours E, Modigliani R, Bouhnik Y; Groupe D'Etude Thérapeutique des Affections Inflammatoires du Tube Digestif. Lémann M, et al. Among authors: lerebours e. Gastroenterology. 2005 Jun;128(7):1812-8. doi: 10.1053/j.gastro.2005.03.031. Gastroenterology. 2005. PMID: 15940616 Clinical Trial.
[Maintenance treatment of Crohn's disease using orally administered mesalazine (Pentasa). A controlled multicenter study. The Study Groups on the Treatment of Inflammatory Digestive Disorders].
Gendre JP, Mary JY, Florent C, Modigliani R, Colombel JF, Soulé JC, Galmiche JP, Lerebours E, Descos L, Viteau JM, et al. Gendre JP, et al. Among authors: lerebours e. Ann Gastroenterol Hepatol (Paris). 1993 Oct;29(5):251-6. Ann Gastroenterol Hepatol (Paris). 1993. PMID: 8250520 Clinical Trial. French.
Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID).
Florent C, Cortot A, Quandale P, Sahmound T, Modigliani R, Sarfaty E, Valleur P, Dupas JL, Daurat M, Faucheron JL, Lerebours E, Michot F, Belaiche J, Jacquet N, Soulé JC, Rothman N, Gendre JP, Malafosse M. Florent C, et al. Among authors: lerebours e. Eur J Gastroenterol Hepatol. 1996 Mar;8(3):229-33. doi: 10.1097/00042737-199603000-00008. Eur J Gastroenterol Hepatol. 1996. PMID: 8724022 Clinical Trial.
Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial.
Marteau P, Lémann M, Seksik P, Laharie D, Colombel JF, Bouhnik Y, Cadiot G, Soulé JC, Bourreille A, Metman E, Lerebours E, Carbonnel F, Dupas JL, Veyrac M, Coffin B, Moreau J, Abitbol V, Blum-Sperisen S, Mary JY. Marteau P, et al. Among authors: lerebours e. Gut. 2006 Jun;55(6):842-7. doi: 10.1136/gut.2005.076604. Epub 2005 Dec 23. Gut. 2006. PMID: 16377775 Free PMC article. Clinical Trial.
Azathioprine withdrawal in patients with Crohn's disease maintained on prolonged remission: a high risk of relapse.
Treton X, Bouhnik Y, Mary JY, Colombel JF, Duclos B, Soule JC, Lerebours E, Cosnes J, Lemann M; Groupe D'Etude Thérapeutique Des Affections Inflammatoires Du Tube Digestif (GETAID). Treton X, et al. Among authors: lerebours e. Clin Gastroenterol Hepatol. 2009 Jan;7(1):80-5. doi: 10.1016/j.cgh.2008.08.028. Epub 2008 Sep 4. Clin Gastroenterol Hepatol. 2009. PMID: 18849016 Clinical Trial.
Osteoporosis in inflammatory bowel disease: effect of calcium and vitamin D with or without fluoride.
Abitbol V, Mary JY, Roux C, Soulé JC, Belaiche J, Dupas JL, Gendre JP, Lerebours E, Chaussade S; Groupe D'etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID). Abitbol V, et al. Among authors: lerebours e. Aliment Pharmacol Ther. 2002 May;16(5):919-27. doi: 10.1046/j.1365-2036.2002.01247.x. Aliment Pharmacol Ther. 2002. PMID: 11966500 Free article. Clinical Trial.
221 results